141 related articles for article (PubMed ID: 4607692)
21. [Changes in some hemodynamic indices and the contractile state of the myocardium during infusion of dopamine in man].
Di Segni E; Capestro F; Curzi G; Di Luzio V; Purcaro A; Soro A; Di Giuseppe F
Boll Soc Ital Cardiol; 1971; 16(10):611-4. PubMed ID: 5147985
[No Abstract] [Full Text] [Related]
22. [Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
Castaldi C; D'Amore F; Materia E; Mauceri M; Rivosecchi L
Minerva Cardioangiol; 1978 Nov; 26(11):751-6. PubMed ID: 724124
[No Abstract] [Full Text] [Related]
23. [Glucagon in cardiogenic shock].
De Ninno F; Celentano V; Giugliano F
Minerva Anestesiol; 1971 May; 37(5):240-6. PubMed ID: 5110768
[No Abstract] [Full Text] [Related]
24. [Special aspects of cardiovascular therapy within the scope of emergency medicine].
Pop T
Klin Anasthesiol Intensivther; 1995; 47():154-60. PubMed ID: 7715172
[No Abstract] [Full Text] [Related]
25. [Experimental and clinical studies on effects of glucagon on the ischmic heart].
Asai Y
Nihon Kyobu Geka Gakkai Zasshi; 1974 Dec; 22(12):1158-71. PubMed ID: 4477168
[No Abstract] [Full Text] [Related]
26. [Glucagon, its general and local action].
Nikolov NA; Abud FA; Sirakova IA
Usp Fiziol Nauk; 1979; 10(4):23-51. PubMed ID: 230660
[No Abstract] [Full Text] [Related]
27. Glucagon? One answer to cardiogenic shock.
Deraney MF
Am J Med Sci; 1971 Mar; 261(3):149-54. PubMed ID: 4326665
[No Abstract] [Full Text] [Related]
28. Glucagon as a myocardial stimulant.
Drug Ther Bull; 1970 Oct; 8(20):77-9. PubMed ID: 5487969
[No Abstract] [Full Text] [Related]
29. [Shock and MDF].
Shimizu R
Kokyu To Junkan; 1972 May; 20(5):433-41. PubMed ID: 4574841
[No Abstract] [Full Text] [Related]
30. [Studies on the cardiac effect of glucagon in patients with chronic failure of left ventricle (author's transl)].
Kuhn H; Jaeschke M; Breithardt G; Loogen F
Z Kardiol; 1978 Apr; 67(4):256-64. PubMed ID: 207029
[No Abstract] [Full Text] [Related]
31. Drug therapy in cardiogenic shock.
Ramdohr B
Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
[No Abstract] [Full Text] [Related]
32. [Glucagon and cardiogenic shock].
Perrelet C; Friedemann M; Aepli R
Schweiz Med Wochenschr; 1970 Dec; 100(50):2168-70. PubMed ID: 5526158
[No Abstract] [Full Text] [Related]
33. [Cardiovascular effects of glucagon].
Liakishev AA; Golikov AP
Kardiologiia; 1972 Jul; 12(7):128-36. PubMed ID: 4364203
[No Abstract] [Full Text] [Related]
34. [Use of glucagon in heart decompensation].
Battaglia A; Mercurio G; Profeta F; Gnoffo R; Raineri A
Boll Soc Ital Cardiol; 1973; 18(12):1231-40. PubMed ID: 4807044
[No Abstract] [Full Text] [Related]
35. [Effect of glucagon on the left ventricular function in patients with congestive heart failure (author's transl)].
Dubiel JS; Pyzik A; Szczeklik J; Dubiel JP; Cibor E
Przegl Lek; 1975; 32(8):662-8. PubMed ID: 1162130
[No Abstract] [Full Text] [Related]
36. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
Nobel-Allen N; Kirsch M; Lucchesi BR
J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
[No Abstract] [Full Text] [Related]
37. Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.
O'Brien ET; Howarth E; Singh SP
J Ir Med Assoc; 1973 Aug; 66(15):415-7. PubMed ID: 4727938
[No Abstract] [Full Text] [Related]
38. [Cardiovascular complications during treatment by verapamil. A propos of 6 cases].
Witchitz S; Haiat R; Tarrade T; Chiche P
Nouv Presse Med; 1975 Feb; 4(5):337-8. PubMed ID: 236544
[No Abstract] [Full Text] [Related]
39. [Peruvoside in clinical practice. Study of a new cardioactive drug in cardiac insufficiency].
Verga L; Alazn R
Minerva Cardioangiol; 1975 Jan; 23(1):43-7. PubMed ID: 1143647
[No Abstract] [Full Text] [Related]
40. [Therapy of nonseptic cardiogenic circulatory failure].
Griebenow R
Klin Anasthesiol Intensivther; 1995; 47():122-8. PubMed ID: 7715169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
